Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | Q9HBH1 | 1/20 | 0.50 | |
| ▸ | SSTR3 | P32745 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.40 |
| ▸ | MEN1 | O00255 | 5/20 | 0.40 |
| ▸ | GLA | P06280 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | NPY1R | P25929 | 1/20 | 0.39 |
| ▸ | NPY2R | P49146 | 1/20 | 0.39 |
| ▸ | NPY4R | P50391 | 1/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7356173 | 0.99 | PDF (0.49) | PDFSSTR3ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL29378049 | 0.88 | PDF (0.51) | PDFSSTR3ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL2567001 | 0.88 | PDF (0.48) | PDFSSTR3ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL8723156 | 0.88 | PDF (0.52) | PDFSSTR3ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL16446037 | 0.88 | PDF (0.50) | PDFSSTR3ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL15286730 | 0.87 | PDF (0.44) | PDFSSTR3ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL5582797 | 0.87 | PDF (0.44) | PDFSSTR3ALDH1A1SMN1; SMN2MAPT | |
| Hydrochloric Acid SCHEMBL4449414 | 0.86 | PDF (0.44) | PDFSSTR3ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL1780776 | 0.86 | PDF (0.46) | PDFSSTR3ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL10943828 | 0.86 | PDF (0.46) | PDFSSTR3ALDH1A1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071253-A1 | METHOD FOR DETECTING THE PRESENCE, IDENTIFICATION AND QUANTIFICATION IN A BLOOD SAMPLE OF ANTICOAGULANTS WHICH ARE BLOOD COAGULATION ENZYMES INHIBITORS, AND MEANS FOR THE IMPLEMENTATION THEREOF | STAGO DIAGNOSTICA (FR) | 2026-03-12 | — | — | US | claimed |
| US-12473584-B2 | Method for detecting the presence, identification and quantification in a blood sample of anticoagulants which are blood coagulation enzymes inhibitors, and means for the implementation thereof | DIAGNOSTICA STAGO (FR) | 2025-11-18 | — | — | US | claimed |
| EP-3891752-B1 | METHOD FOR DETECTING THE PRESENCE, IDENTIFICATION AND QUANTIFICATION IN A BLOOD SAMPLE OF ANTICOAGULANTS WHICH ARE INHIBITORS OF BLOOD COAGULATION ENZYMES, AND MEANS FOR THE IMPLEMENTATION THEREOF | STAGO DIAGNOSTICA (FR) | 2025-08-13 | — | — | EP | claimed |
| US-20240353431-A1 | SELECTIVE MEASUREMENT OF HUMAN FACTOR VIII | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-10-24 | — | — | US | claimed |
| EP-4388124-A1 | SELECTIVE MEASUREMENT OF HUMAN FACTOR VIII | Takeda Pharmaceutical Company Limited (JP) | 2024-06-26 | — | — | EP | claimed |
| CN-117836425-A | Selective measurement of human factor VIII | 武田药品工业株式会社 | 2024-04-05 | — | — | CN | claimed |
| WO-2023021311-A1 | SELECTIVE MEASUREMENT OF HUMAN FACTOR VIII | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-02-23 | — | — | WO | claimed |
| US-20220380833-A1 | Universal Calibration Method for Assaying Enzymatic Inhibitors | DIAGNOSTICA STAGO (FR) | 2022-12-01 | — | — | US | claimed |
| EP-0476715-B1 | Method and composition for the determination of chloride ions in fluids | UNIV SOUTHERN AUSTRALIA (AU) | 1996-12-18 | — | — | EP | claimed |
| US-5409814-A | Quantitative analysis using enzymes | BOEHRINGER MANNHEIM GMBH (DE) | 1995-04-25 | — | — | US | claimed |
| EP-0476715-A2 | Method and composition for the determination of chloride ions in fluids | THE FLINDERS UNIVERSITY OF SOUTH AUSTRALIA (AU) | 1992-03-25 | — | — | EP | claimed |
| US-20260071253-A1 | METHOD FOR DETECTING THE PRESENCE, IDENTIFICATION AND QUANTIFICATION IN A BLOOD SAMPLE OF ANTICOAGULANTS WHICH ARE BLOOD COAGULATION ENZYMES INHIBITORS, AND MEANS FOR THE IMPLEMENTATION THEREOF | STAGO DIAGNOSTICA (FR) | 2026-03-12 | — | — | US | disclosed |
| US-20260014236-A1 | ACTIVATORS OF COAGULATION FACTOR X AND FORMULATIONS THEREOF FOR TREATING BLEEDING DISORDERS | JIANGSU BIOJETAY BIOTECHNOLOGY CO., LTD. (CN) | 2026-01-15 | — | — | US | disclosed |
| US-20250389737-A1 | FACTOR Xa REAGENT | INSTR LABORATORY CO (US) | 2025-12-25 | — | — | US | disclosed |
| EP-4667582-A1 | FACTOR XA REAGENT | Instrumentation Laboratory Company (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-0476715-A2 | Method and composition for the determination of chloride ions in fluids | THE FLINDERS UNIVERSITY OF SOUTH AUSTRALIA (AU) | 1992-03-25 | — | — | EP | disclosed |
| EP-0471391-A2 | Determination of ions in fluids | THE FLINDERS UNIVERSITY OF SOUTH AUSTRALIA (AU) | 1992-02-19 | — | — | EP | disclosed |
| EP-0309525-A1 | DETERMINATION OF IONS IN FLUIDS | THE FLINDERS UNIVERSITY OF SOUTH AUSTRALIA (AU) | 1989-04-05 | — | — | EP | disclosed |
| WO-1988008137-A1 | DETERMINATION OF IONS IN FLUIDS | THE FLINDERS UNIVERSITY OF SOUTH AUSTRALIA (AU) | 1988-10-20 | — | — | WO | disclosed |
| EP-0286039-A2 | Determination of potassium ions in fluids | THE FLINDERS UNIVERSITY OF SOUTH AUSTRALIA (AU) | 1988-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071253-A1 | METHOD FOR DETECTING THE PRESENCE, IDENTIFICATION AND QUANTIFICATION IN A BLOOD SAMPLE OF ANTICOAGULANTS WHICH ARE BLOOD COAGULATION ENZYMES INHIBITORS, AND MEANS FOR THE IMPLEMENTATION THEREOF | TFPI, F13B, TFPI2 | PDF 4130/4885SSTR3 4809/4885ALDH1A1 1662/4885 |
| US-20250389737-A1 | FACTOR Xa REAGENT | F9, F11, TFPI | PDF 1696/4885SSTR3 4536/4885ALDH1A1 3524/4885 |
| US-20260014236-A1 | ACTIVATORS OF COAGULATION FACTOR X AND FORMULATIONS THEREOF FOR TREATING BLEEDING DISORDERS | F8, F5, F12 | PDF 840/4885SSTR3 2459/4885ALDH1A1 4656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.